Diaceutics has announced an investment of £1m ($1.1m) to expand and enhance its...
- Medable unveils telemedicine solution only for clinical trials
- SubjectWell raises funds to expand patient recruitment marketplace
- Diaceutics invests in patient data to improve outcomes
- Parexel partners with Clariness to speed up clinical trial recruitment
- Broader inclusion criteria to double eligible cancer patients for clinical trials, finds study
Medable unveils telemedicine solution only for clinical trials
US-based Medable has unveiled a telemedicine solution designed only for clinical trials.
SubjectWell raises funds to expand patient recruitment marketplace
SubjectWell has raised $10m through Series A funding round, led by US-based venture capital firm Windham Venture Partners.
Diaceutics invests in patient data to improve outcomes
Diaceutics has announced an investment of £1m ($1.1m) to expand and enhance its data lake by acquiring another 16 million patient records a year.
Patients with ESRD experience extremely high mortality, review says
Nephrology association ERA-EDTA has revealed that patients with end-stage renal disease (ESRD) experience extremely high morbidity and mortality.
Parexel partners with Clariness to speed up clinical trial recruitment
Parexel, a company with a focus on developing new therapies to improve health, has entered into a strategic partnership with Clariness, a global patient recruitment company, to speed up clinical trial recruitment and patient engagement in China.
Myeloma UK launches research programme to support myeloma clinical trials
Myeloma UK has launched a new research programme to continue providing support to patient-centric myeloma clinical trials in the country - the UK Myeloma Research Alliance-Myeloma UK-Concept and Access Research Programme (UKMRA-Myeloma UK-CARP).
CRF Bracket launches as Signant Health to focus on drug development
CRF Bracket, which was formed as a merged entity of CRF Health and Bracket, was launched as Signant Health.
Hoth Therapeutics to begin production of BioLexa for upcoming clinical trials
Hoth Therapeutics has announced the formation of its subsidiary, Hoth Therapeutics Australia, in preparation for upcoming clinical studies.
US FDA issues draft guidance on increasing patient diversity in clinical trials
The US Food and Drug Administration (FDA) has issued a draft guidance as part of its efforts to encourage drug developers to enroll more patients in clinical trials.
Broader inclusion criteria to double eligible cancer patients for clinical trials, finds study
A study assessing the health records of more than 10,500 patients with advanced non-small cell lung cancer (aNSCLC) from ASCO’s CancerLinQ database found that the use of expanded clinical trial inclusion criteria would nearly double the percentage of eligible cancer patients to enroll in clinical trials.